BAG Health Care

What BAG Health Care does

BAG Health Care GmbH is a Germany-based contract development and manufacturing organization (CDMO) that specializes in the aseptic filling and lyophilization (freeze drying) of sterile parenteral drugs. Founded in 1947 and headquartered in Lich, Hesse, the company is a wholly-owned subsidiary of BAG Holding GmbH, which also owns BAG Diagnostics GmbH. The company employs 51–100 people and operates a single manufacturing site in central Germany, positioned as a European pharmaceutical manufacturing hub.

Its core technical platform comprises GMP-compliant aseptic fill-and-finish on an Annex 1-compliant Bausch + Ströbel line (vials 2R–50H, fill volumes 1.2L–200L, speeds up to 6,000 vials/hour, dead volumes under 500 mL) and a lyophilization suite of three freeze dryers (4, 8, and 17 m²) supporting batch sizes from 500 to 70,000 units. The 8 m² unit, supplied by HOF and installed in 2025, is undergoing IQ/OQ/PQ qualification. In-house analytical laboratories provide HPLC, Karl-Fischer titration, FT-IR spectroscopy, polarimetry, refractometry, viscosity testing, and elemental impurity control, supporting products from raw material testing through release and stability studies. Secondary packaging, regulatory compliance (IMPD/MAA support), and technology transfer round out an integrated six-service offering.

BAG Health Care generates revenue through project-based, fee-for-service CDMO contracts with pharmaceutical companies, biotech innovators, and specialty pharma clients. Pricing is quote-based and negotiated per project; there is no public disclosure of unit economics. The go-to-market is direct enterprise sales led by a four-person senior team (CEO Dr. Nicolas Sachsenberg, Head of New Business Development Dr. Klaus Dörre, Head of Client Management and Sales Nico Meyer, Head of Project Management and Product Transfer Janine Droß), supplemented by conference participation (Berlin, Basel, Rotterdam in 2026) and digital presence. The company's explicit positioning targets small and midsized batches that larger CMOs deprioritize, with a stated emphasis on responsive execution and price/performance competitiveness in the European sterile injectables market.

Name

BAG Health Care

Legal name

BAG Health Care GmbH

Website

https://bag-healthcare.com

Company type

Private

Founded year

1947

Operating status

Operating

Headcount range

51–100 employees

Short description

BAG Health Care is a Germany-based CDMO specializing in aseptic filling and lyophilization of sterile parenteral drugs for pharmaceutical companies, biotech innovators, and specialty pharma, focused on small and midsized batches across clinical and commercial supply.

Ownership category

akta.pro rank

Headquarters

HQ city

Lich

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Contract Manufacturing (CDMO Services): BAG Health Care operates as a Contract Development and Manufacturing Organization (CDMO), generating revenue through fee-for-service manufacturing contracts. Services include aseptic filling, lyophilization, analytical services, secondary packaging, regulatory compliance support, and technology transfer. Revenue is project-based with engagements typically spanning from clinical phase through commercial launch.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

BAG Health Care is a Germany-based Contract Development and Manufacturing Organization (CDMO) that provides aseptic filling and lyophilization services for small and midsized batches of sterile parenteral drugs. The integrated portfolio spans aseptic filling, freeze drying, in-house analytical testing, secondary packaging, regulatory compliance support, and technology transfer from clinical through commercial production.

Product overview

BAG Health Care is a Germany-based Contract Development and Manufacturing Organization (CDMO) specializing in small and midsized batches of sterile parenteral drugs. The company offers an integrated service portfolio centered on six core offerings: Aseptic Filling (using Annex 1-compliant Bausch + Ströbel equipment and small rotary filling lines for vials 2R-50H), Lyophilization (using three freeze dryers of 4, 8, and 17 m²), Analytical Services (HPLC, Karl-Fischer, FT-IR, and other testing methods), Secondary Packaging, Regulatory Compliance, and Technology Transfer. The services are designed to support clients from early-phase clinical production through commercial launch, with a focus on responsive, GMP-compliant manufacturing for injectables.

Differentiator

Problem solved

Functional benefit

Products and services

• Aseptic Filling GMP-compliant aseptic filling and finishing of sterile parenteral drugs in vials from 2R to 50H, supporting clinical and commercial production with Annex 1-compliant equipment from Bausch + Ströbel and small rotary filling lines. Includes fill volumes from 1.2L to 200L with precision piston pumps and filling speeds up to 6,000 vials/hour.
• Lyophilization GMP-qualified freeze drying services for biologics, peptides, and sensitive active ingredients using three freeze dryers (4, 8, and 17 m²) supporting batch sizes from 500 to 70,000 units (2R). Capable of processing complex formulations including oily or slightly viscous liquids from early-phase to commercial production.
• Analytical Services Internal laboratory services supporting the entire lifecycle of parenteral drugs from raw material testing through release and stability studies. Capabilities include HPLC (UV/VIS, DAD), Karl-Fischer titration, FT-IR spectroscopy, polarimetry, refractometry, viscosity testing, and elemental impurity control.
• Secondary Packaging Safe and secure secondary packaging services for sterile pharmaceutical products, ensuring products are prepared and labeled for shipment in compliance with GMP requirements.
• Regulatory Compliance Regulatory compliance services providing confidence through quality assurance, supporting IMPD (Investigational Medicinal Product Dossier) and MAA (Marketing Authorisation Application) submissions across EU and international markets.
• Technology Transfer Comprehensive technology transfer services from kickoff to commercial launch, including process optimization and GMP scale-up, managed by dedicated project management and product transfer staff.

Quantifiable outcome

• Reduced product loss through precision filling with dead volumes under 500mL
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• BAG Holding GmbHcoreOthersParent company providing shared services including human resources management, IT infrastructure, and data protection coordination across the BAG Group of companies. BAG Holding GmbH is the ultimate parent entity of BAG Health Care GmbH and BAG Diagnostics GmbH.
• BAG Diagnostics GmbHminorOthersSister company within the BAG Group operating in the diagnostics sector. Both companies operate under the shared services umbrella of BAG Holding GmbH.
• Bausch + StröbelcoreTechnology or IntegrationEquipment supplier providing the Annex 1-compliant aseptic filling line used at BAG Health Care's facility. Bausch + Ströbel is a leading manufacturer of pharmaceutical processing and packaging equipment.
• HOF (Hof Sondermaschinenbau)coreTechnology or IntegrationEquipment supplier providing the 8 m² freeze dryer installed to expand lyophilization capacity. HOF is a manufacturer of industrial freeze drying equipment for pharmaceutical applications.

Scale indicators5 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Recipharm: Large European CDMO with aseptic fill-finish and lyophilization capabilities across multiple sites. Comparable sterile injectable services but with significantly broader scale and service portfolio than BAG.
• Siegfried Holding: Swiss-based CDMO with global sterile fill-finish capabilities across small and large molecule APIs including injectables. A larger incumbent in the same parenteral CDMO space, offering more capacity and geographic reach than BAG.
• Catalent: Global CDMO with extensive sterile fill-finish and lyophilization capacity for injectables and biologics. Broad incumbent serving similar pharma/biotech customer base with much larger scale and geographic footprint.
• Thermo Fisher Scientific (Patheon CDMO): Global CDMO offering aseptic fill-finish and lyophilization through its pharmaceutical services division. Large incumbent with sterile injectable capabilities comparable to BAG's core offering, though at significantly larger scale.
• Lonza: Swiss global CDMO leader providing mammalian and microbial biologics manufacturing including aseptic fill-finish and lyophilization. Major incumbent competing for high-value biologics programs that BAG also targets.

Direct peers

• Vetter Pharma: German-based CDMO specializing in aseptic fill-finish of injectable drugs, including complex biologics requiring lyophilization. Closest direct comparable to BAG Health Care given overlapping geography, fill-finish focus, and small/midsized-batch service profile.
• Rommelag Engineering: German CDMO specializing in aseptic filling using blow-fill-seal technology alongside conventional aseptic fill-finish for parenterals. Comparable sterile CDMO services, GMP compliance focus, and European market presence.
• Aenova Group: German-headquartered CDMO offering sterile fill-finish and lyophilization services for parenteral drugs across multiple sites in Europe. Directly comparable to BAG in service portfolio, regulatory positioning, and European customer base.
• NextPharma: European CDMO offering sterile fill-finish, lyophilization, and analytical services for injectable pharmaceuticals. Comparable mid-sized European CDMO competing for similar biotech and pharma clients.

Regional players

• GRAM (Grupo Grifols Manufacturing): European CDMO providing aseptic fill-finish and lyophilization of injectable biologics primarily for the European market. Comparable mid-sized European peer with similar sterile manufacturing capabilities, though focused on plasma-derived products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/bag-health-care-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BAG Health Care